Hedera Dx
Hedera Dx was created in 2021 with the mission to give access to liquid biopsy technologies to patients at risk of or already suffering from cancer.
Lausanne, Switzerlandwww.hederadx.com ↗
Total raised
€29M
€29,000,000
Funding rounds
2
Investors
10
distinct backers
Active since
2022-09
latest 2025-05
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood49
base rate 44% for Series A
- ▲ In typical raise window
- ▼ Low backer re-investment
Exit likelihood12
base rate 12% (2+ rounds)
Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-27 | Series A | €15M | Eyrir Venture Management,Helsana HealthInvest,Inventure,Tesi,Top Harvest Capital,Vsquared Ventures | View deal → |
| 2022-09-21 | Other | €14M | Air Street Capital,Adam Ghobarah,Amino Collective,GRIDS Capital,Inventure | View deal → |
Investors
10Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy